Phar Vision Advisers, LLC Trans Medics Group, Inc. Transaction History
Phar Vision Advisers, LLC
- $69.6 Billion
- Q2 2025
A detailed history of Phar Vision Advisers, LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Phar Vision Advisers, LLC holds 1,970 shares of TMDX stock, worth $227,909. This represents 0.38% of its overall portfolio holdings.
Number of Shares
1,970Holding current value
$227,909% of portfolio
0.38%Shares
1 transactions
Others Institutions Holding TMDX
# of Institutions
415Shares Held
29.8MCall Options Held
1.19MPut Options Held
777K-
Vanguard Group Inc Valley Forge, PA3.6MShares$416 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$306 Million0.01% of portfolio
-
State Street Corp Boston, MA1.29MShares$149 Million0.01% of portfolio
-
Fil LTD Hamilton, D01.06MShares$122 Million0.13% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL956KShares$111 Million0.03% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $3.68B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...